Wednesday, January 7, 2009

For Kids...For Teens...For Parents...
Nemours Center for Childhood Cancer Research
Site Navigation
 
 

Publications

Ayyappan Rajasekaran, PhD

A.K. RajasekaranRajasekaran S.A., S.P. Barwe, J. Gopal, S. Ryazantsev, E.E. Schneeberger, and Rajasekaran A.K. (2007). Na,K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292: G124-G133.

Barwe S.P., S. Kim, S.A. Rajasekaran, J.Bowie, and Rajasekaran A.K. (2007). Janus model of the Na,K-ATPase β-subunit transmembrane domain and its implications in α/β assembly and β-β homo-oligomerization. J Mol Biol. 365:706-714.

Barwe S.P., R.S.Maul, J.J.Christiansen, G. Anilkumar, C.R.Cooper, D.B.Kohn, and Rajasekaran A.K. (2007). Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix. Int J Oncol. 4:899-904.

Cui X., L. Zhang, Rajasekaran A.K., S.Hazra, N.Cacalano. S.M.Dubinett (2007). Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer. Oncogene 26:4253-4260.

Olson W.C., W.D. Heston and Rajasekaran A.K. (2007). Clinical trials of cancer therapies targeting prostate-specific membrane antigen. RRCT 2:182-190.

Goodman, Jr O.B . S. P Barwe, P. McPherson, J. H. Keen , A.Vasko, D. M. Nanus, N. H. Bander, and Rajasekaran A. K. (2007) . Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2. Int J Oncol. 5:1199-2003.

Seligson D., Rajasekaran S.A., Yu H., Liu X., Eeva M., Tze S., Ball Jr. W., Horvath S., deKernion J., and Rajasekaran A.K. (2008) Na,K-ATPase α1-subunit predicts survival in renal clear cell carcinoma. J. Urol. 179: 338-345.

Rajasekaran, S.A., K.W. Beyenbach and Rajasekaran A.K.. (2008) Interactions of tight junctions with membrane channels and transporters. Biochim Biophys ACTA, 1778(3):757-69.

Inge, L.J., S.A.Rajasekaran, K.Yoshimoto, P.S.Mischel, W.McBride, E.Landow and Rajasekaran A.K.. (2008) Evidence for a potential tumor suppressor role for Na,K-ATPase β1-subunit. Histol Histopathol 23(4):459-67.

Inge, L.J., S.A. Rajasekaran, S. Ryazantsev, C.M.Ewing, W.Isaacs and Rajasekaran A.K.. α-catenin overrides Src-dependent activation of β-catenin oncogenic signaling (Molecular Cancer Therapeutics, 2008 June; 7(6): 1386-97).

Rajasekaran, S., Christiansen, J.J., Schmid, I.,Ryanzantsev S., Oshima, E., Sakamoto, K., Weinstein, J., Rao, N., Rajasekaran, A.K. (2008). Prostate specific membrane antigen associates with anaphase promoting complex and induces chromosomal instability. (Molecular Cancer Therapeutics 2008: 7(7): 2142-2151).

Rajasekaran, S and Rajasekaran, A.K. (2008). Na,K-ATPase and tight junctions (Frontiers in Bioscience, in press).

Rajasekaran S A. and Rajasekaran A.K. (2008). Epithelial to Mesenchymal Transition, Cancer Encyclopedia (in press).

Reckamp K., B Gardner, R. Figlin, D. Elashoff, K.Krysan, M. Dohadwala, J.Mao, S. Sharma, L.Inge, Rajasekaran A.K., S. Dubinett (2008). Tumor response to combination celecoxib and erlotinib therapy in NSCLC is associated with a low baseline matrix metalloproteinase-9 and a decline in serum soluble E-cadherin (Journal of Thoracic Oncology 2008 Feb; 3(2): 117-24).

 
Sigrid Rajasekaran, PhD

S.A. RajasekaranRajasekaran S.A., S.P. Barwe, J. Gopal, S. Ryazantsev, E.E. Schneeberger, and Rajasekaran A.K. (2007). Na,K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292: G124-G133.

Barwe S.P., S. Kim, S.A. Rajasekaran, J.Bowie, and Rajasekaran A.K. (2007). Janus model of the Na,K-ATPase β-subunit transmembrane domain and its implications in α/β assembly and β-β homo-oligomerization. J Mol Biol. 365:706-714.

Seligson D., Rajasekaran S.A., Yu H., Liu X., Eeva M., Tze S., Ball Jr. W., Horvath S., deKernion J., and Rajasekaran A.K. (2008) Na,K-ATPase 1-subunit predicts survival in renal clear cell carcinoma. J. Urol. 179: 338-345.

Rajasekaran, S.A., K.W. Beyenbach and Rajasekaran A.K.. (2008) Interactions of tight junctions with membrane channels and transporters. Biochim Biophys ACTA, 1778(3):757-69.

Inge, L.J., S.A.Rajasekaran, K.Yoshimoto, P.S.Mischel, W.McBride, E.Landow and Rajasekaran A.K.. (2008) Evidence for a potential tumor suppressor role for Na,K-ATPase β1-subunit. Histol Histopathol 23(4):459-67.

Inge, L.J., S.A. Rajasekaran, Wolle D., Barwe S.P., S. Ryazantsev, C.M.Ewing, W.Isaacs and Rajasekaran A.K.. α-catenin overrides Src-dependent activation of β-catenin oncogenic signaling (Molecular Cancer Therapeutics 7: 1386-1397).

Rajasekaran, S., Christiansen, J.J., Schmid, I., Oshima, E., Ryanzantsey S., Sakamoto, K., Weinstein, J., Rao, N., Rajasekaran, A.K. (2008). Prostate specific membrane antigen associates with anaphase promoting complex and induces chromosomal instability. (Molecular Cancer Therapeutics 2008; 7(7): 2142-2151).

Rajasekaran, S and Rajasekaran, A.K. (2008). Na,K-ATPase and tight junctions (Frontiers in Bioscience, in press).

Rajasekaran S A. and Rajasekaran A.K. (2008). Epithelial to Mesenchymal Transition, Cancer Encyclopedia (in press).

 
Robert Mason, PhD

Robert MasonHassanein, M., Korant, B. D., Lu, G. and Mason, R. W. (2007) Expression of Cathepsin P mRNA, Protein and Activity in the Rat Choriocarcinoma Cell Line, Rcho-1, During Giant Cell Transformation” Placenta, 28, 912-919.

Hassanein, M., Xue, F., Seto, C.T. and Mason, R. W. (2007) “Development of a specific inhibitor for the placental protease, cathepsin P” Arch. Biochem. Biophys., 464, 288-294.

Mason, R.W. (2008) “Emerging Roles of Placental Cathepsins” Placenta. 29, 385-390

Sireesha, G.V., Mason, R.W., Hassanein, M., Tonac, S.,Navarrete Santos, A., Fischer, B., Seshagiri, P.B. (2008) “Role of Cathepsins in Blastocyst Hatching in the Golden Hamster” Mol. Human Reprod. 14, 337-346

 
 
Tool Box